The P-gp overexpressed breast cancer cell line MDA435/LCC6MDR was used to investigate the most recently designed ningalin analogues by direct comparison with wild type MDA435/LCC6 (Table 1) [45,50,51,52]. This evidence concerns the gene PGP and breast cancer.